Disulfiram: A Proven Pharmacological Deterrent for Alcohol Dependence
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.38 | $41.40 (0%) | 🛒 Add to cart |
| 60 | $1.11 | $82.80 $66.64 (20%) | 🛒 Add to cart |
| 90 | $1.02 | $124.20 $91.89 (26%) | 🛒 Add to cart |
| 120 | $0.98 | $165.60 $118.14 (29%) | 🛒 Add to cart |
| 180 | $0.94 | $248.40 $169.64 (32%) | 🛒 Add to cart |
| 270 | $0.91 | $372.61 $245.37 (34%) | 🛒 Add to cart |
| 360 | $0.89
Best per pill | $496.81 $320.10 (36%) | 🛒 Add to cart |
Synonyms | |||
Disulfiram is an aversive therapy medication indicated as an adjunct in the management of chronic alcohol use disorder. It functions by producing a highly unpleasant physiological reaction upon the ingestion of ethanol, thereby creating a powerful psychological deterrent to drinking. This mechanism supports the maintenance of sobriety within a comprehensive treatment plan that includes counseling and psychosocial support. Its efficacy is well-documented in clinical literature, making it a cornerstone of pharmacological intervention for motivated patients committed to abstinence.
Features
- Active Pharmaceutical Ingredient (API): Disulfiram.
- Standard tablet strengths: 250 mg and 500 mg.
- Mechanism of Action: Irreversible inhibition of the enzyme aldehyde dehydrogenase (ALDH).
- Pharmacokinetics: Rapidly absorbed from the GI tract; undergoes extensive metabolism.
- Reaction Trigger: Concomitant consumption of any form of ethanol.
- Administration: Oral, once-daily dosing.
Benefits
- Creates a powerful, immediate physiological deterrent to alcohol consumption, reinforcing commitment to abstinence.
- Provides patients with a tangible tool to manage cravings and avoid relapse during the early stages of recovery.
- Allows patients to regain a sense of control over their behavior by making the consequences of drinking predictable and highly undesirable.
- Serves as an integral component of a multifaceted treatment plan, improving long-term sobriety rates when combined with behavioral therapy.
- The once-daily dosing regimen supports adherence and simplifies integration into a daily routine.
Common use
Disulfiram is exclusively used for the management of chronic alcohol use disorder in patients who wish to maintain a state of enforced sobriety. It is not a cure for alcoholism, nor does it diminish the craving for alcohol. Its utility is greatest in highly motivated, fully informed patients who are concurrently participating in a supportive treatment program that includes psychological counseling, social support, and regular medical supervision. The patient must explicitly consent to this form of therapy after a thorough explanation of the disulfiram-ethanol reaction.
Dosage and direction
Initialization: Treatment should never be initiated until the patient has abstained from alcohol for at least 12 hours and a negative baseline breathalyzer or blood alcohol test is confirmed. Initial Dosage: The maximum recommended initial dose is 500 mg daily for one to two weeks. Maintenance Dosage: The usual maintenance dose is 250 mg daily (range 125 mg to 500 mg). The dosage may be adjusted based on patient response and tolerability. Administration: The tablet should be taken orally once daily, preferably in the morning. It can be crushed and mixed with liquid if necessary. Treatment should continue until the patient is fully established in a supportive psychosocial program and demonstrates self-motivated, sustained abstinence.
Precautions
- Patients must be explicitly warned that the disulfiram-ethanol reaction can occur for up to 14 days after the last dose of disulfiram.
- Patients must avoid all sources of ethanol, including but not limited to: alcoholic beverages, sauces, vinegars, mouthwashes, elixirs, tonics, and certain topical preparations or aftershaves.
- Use with caution in patients with diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, chronic and acute nephritis, hepatic disease or impairment, and cardiovascular disease.
- Periodic monitoring of liver function tests (transaminases) is mandatory before initiation and at least every 2-3 months during the first year of therapy, and periodically thereafter.
- May cause drowsiness; patients should exercise caution when operating machinery or driving until they know how the medication affects them.
Contraindications
- Hypersensitivity to disulfiram or any other component of the formulation.
- Severe myocardial disease or coronary occlusion.
- Psychosis.
- Patients who are receiving or have recently received metronidazole, paraldehyde, alcohol, or alcohol-containing preparations.
- Pregnancy, unless the potential benefit justifies the potential risk to the fetus.
Possible side effect
The most significant side effect is the disulfiram-ethanol reaction (DER), characterized by: flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion. In severe cases, respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death can occur.
Non-Reaction Related Side Effects:
- Common: Drowsiness, fatigue, headache, metallic or garlic-like aftertaste.
- Infrequent: Allergic dermatitis, skin eruptions.
- Rare: Hepatotoxicity (including hepatitis and hepatic failure), optic neuritis, peripheral neuropathy, polyneuritis, psychiatric disturbances.
Drug interaction
Disulfiram inhibits several hepatic microsomal enzymes, notably those of the CYP450 2E1 and 2C9 families, leading to numerous potential interactions:
- Warfarin: Potentiates anticoagulant effect, increasing prothrombin time and risk of hemorrhage. Warfarin dosage must be reduced.
- Phenytoin: Increases phenytoin serum levels, potentiating its therapeutic and toxic effects. Monitor phenytoin levels closely.
- Benzodiazepines (e.g., diazepam, chlordiazepoxide): May increase serum levels and prolong sedative effects.
- Tricyclic Antidepressants: Metabolism may be inhibited.
- Theophylline: May decrease theophylline clearance, increasing the risk of toxicity.
- Isoniazid: Increased risk of unsteadiness, dizziness, and behavioral changes.
- Metronidazole: Concomitant use is contraindicated due to risk of psychotic reactions.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is not remembered until the next day, the patient should skip the missed dose and resume the usual dosing schedule. Do not double the dose to make up for a missed one. Maintaining a consistent daily level of the drug is important for its deterrent effect.
Overdose
Symptoms: Overdose in the absence of alcohol may present with nausea, vomiting, GI upset, dizziness, ataxia, and neurological symptoms. The most severe manifestations of overdose are seen in conjunction with alcohol ingestion, leading to an extreme and potentially fatal disulfiram-ethanol reaction as described above. Management: There is no specific antidote for disulfiram overdose. Management is entirely supportive and symptomatic. In case of a severe DER, supportive measures to maintain respiration and cardiovascular function are critical. Treatment may include oxygen, intravenous fluids and electrolytes, vasopressors for hypotension, and anticonvulsants for seizures. Gastric lavage may be considered if ingestion was recent and no alcohol has been consumed.
Storage
Store at controlled room temperature, 20°C to 25°C (68°F to 77°F). Dispense in a tight, light-resistant container. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational and professional medical purposes only and is not a substitute for the professional judgment of a healthcare provider. The content provided is based on the drug’s prescribing information but may not encompass all available data. The author and publisher are not responsible for any errors, omissions, or for any outcomes related to the use of this information. Always read the official package insert and consult with a qualified physician for diagnosis and treatment decisions, including dosage and potential interactions. Treatment must be initiated and supervised by a physician experienced in the management of chronic alcohol use disorder.
Reviews
“Disulfiram remains an invaluable tool in our addiction medicine arsenal. Its efficacy is directly proportional to the patient’s motivation and understanding of the consequences. For the right patient, it is a powerful enforcer of the commitment to sobriety.” – Addiction Psychiatrist, 15 years of experience.
“In my clinical practice, I have found disulfiram to be most effective when used within a structured treatment agreement. It provides a concrete ’line in the sand’ for patients, but it must be part of a larger therapeutic framework that addresses the underlying causes of addiction.” – Certified Addiction Specialist.
“While newer medications have emerged, disulfiram’s aversive mechanism is unique. The key to success is meticulous patient selection, comprehensive education, and unwavering informed consent. The potential severity of the ethanol reaction cannot be overstated.” – Clinical Pharmacologist.